[68Ga]Ga-DWJ155

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [68Ga]Ga-DWJ155, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers [Phase 1]